Lipocalin-2: a therapeutic target to overcome neurodegenerative diseases by regulating reactive astrogliosis.


Journal

Experimental & molecular medicine
ISSN: 2092-6413
Titre abrégé: Exp Mol Med
Pays: United States
ID NLM: 9607880

Informations de publication

Date de publication:
10 2023
Historique:
received: 21 06 2023
accepted: 17 07 2023
revised: 14 07 2023
medline: 2 11 2023
pubmed: 2 10 2023
entrez: 1 10 2023
Statut: ppublish

Résumé

Glial cell activation precedes neuronal cell death during brain aging and the progression of neurodegenerative diseases. Under neuroinflammatory stress conditions, lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin or 24p3, is produced and secreted by activated microglia and reactive astrocytes. Lcn2 expression levels are known to be increased in various cells, including reactive astrocytes, through the activation of the NF-κB signaling pathway. In the central nervous system, as LCN2 exerts neurotoxicity when secreted from reactive astrocytes, many researchers have attempted to identify various strategies to inhibit LCN2 production, secretion, and function to minimize neuroinflammation and neuronal cell death. These strategies include regulation at the transcriptional, posttranscriptional, and posttranslational levels, as well as blocking its functions using neutralizing antibodies or antagonists of its receptor. The suppression of NF-κB signaling is a strategy to inhibit LCN2 production, but it may also affect other cellular activities, raising questions about its effectiveness and feasibility. Recently, LCN2 was found to be a target of the autophagy‒lysosome pathway. Therefore, autophagy activation may be a promising therapeutic strategy to reduce the levels of secreted LCN2 and overcome neurodegenerative diseases. In this review, we focused on research progress on astrocyte-derived LCN2 in the central nervous system.

Identifiants

pubmed: 37779143
doi: 10.1038/s12276-023-01098-7
pii: 10.1038/s12276-023-01098-7
pmc: PMC10618504
doi:

Substances chimiques

Lipocalin-2 0
Lipocalins 0
NF-kappa B 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2138-2146

Informations de copyright

© 2023. The Author(s).

Références

Acta Neuropathol. 2010 Jan;119(1):7-35
pubmed: 20012068
Rev Neurosci. 2017 Nov 27;28(8):861-868
pubmed: 28704199
J Biol Chem. 1995 Nov 10;270(45):26723-6
pubmed: 7592901
Neuron. 2015 Jan 7;85(1):101-115
pubmed: 25533482
Exp Biol Med (Maywood). 2016 Jan;241(1):25-30
pubmed: 26129883
Mol Endocrinol. 2006 Apr;20(4):904-15
pubmed: 16322095
Science. 2018 Oct 12;362(6411):181-185
pubmed: 30309945
Exp Neurobiol. 2014 Jun;23(2):155-62
pubmed: 24963280
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Science. 2013 Jan 11;339(6116):156-61
pubmed: 23307732
J Invest Dermatol. 2016 Jul;136(7):1418-1428
pubmed: 26979478
Cold Spring Harb Perspect Biol. 2015 Aug 20;8(2):a020453
pubmed: 26492571
Neurosci Lett. 2014 Apr 17;565:30-8
pubmed: 24406153
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4069-74
pubmed: 23431168
Nat Neurosci. 2020 Dec;23(12):1555-1566
pubmed: 33199896
Mol Brain. 2020 Jun 8;13(1):89
pubmed: 32513213
Neurobiol Dis. 2020 Sep;143:105008
pubmed: 32622920
Nature. 2017 Jan 26;541(7638):481-487
pubmed: 28099414
Cell. 1995 May 19;81(4):525-31
pubmed: 7758106
J Neuroinflammation. 2011 Sep 26;8:124
pubmed: 21943033
Blood. 2014 Feb 13;123(7):1079-89
pubmed: 24398327
Lancet Neurol. 2016 Aug;15(9):944-953
pubmed: 27291520
J Am Heart Assoc. 2014 Apr 10;3(2):e000837
pubmed: 24721803
Glia. 1988;1(1):2-9
pubmed: 2976736
Neuron. 1999 Jun;23(2):297-308
pubmed: 10399936
Nat Rev Neurosci. 2006 Mar;7(3):194-206
pubmed: 16495941
Science. 2008 Jun 20;320(5883):1638-43
pubmed: 18566287
Biochim Biophys Acta. 2013 May;1832(5):660-73
pubmed: 23376114
Biomarkers. 2015;20(8):565-71
pubmed: 26671823
Front Immunol. 2020 Jul 08;11:1024
pubmed: 32733433
Neuron. 2021 Jan 20;109(2):222-240
pubmed: 33271068
Mol Reprod Dev. 1997 Apr;46(4):507-14
pubmed: 9094098
Neurosci Biobehav Rev. 2015 Feb;49:135-56
pubmed: 25511817
Glia. 2011 Dec;59(12):1911-22
pubmed: 22170100
Neuron. 2008 Nov 6;60(3):430-40
pubmed: 18995817
Neuropathol Appl Neurobiol. 2010 Jun;36(4):285-99
pubmed: 20002312
Annu Rev Neurosci. 2012;35:369-89
pubmed: 22715882
J Immunol. 2005 Oct 1;175(7):4320-30
pubmed: 16177072
Biochem Biophys Res Commun. 2018 Jun 2;500(2):344-350
pubmed: 29654755
Nat Rev Neurosci. 2020 Mar;21(3):139-152
pubmed: 32042145
J Biol Chem. 2012 Feb 10;287(7):4808-17
pubmed: 22117066
Mol Cell Endocrinol. 2016 Jul 15;430:68-76
pubmed: 27090568
J Neurosci. 2012 May 2;32(18):6391-410
pubmed: 22553043
Glia. 2005 Jun;50(4):307-320
pubmed: 15846804
Arch Neurol. 1992 May;49(5):492-7
pubmed: 1580811
Clin J Am Soc Nephrol. 2008 May;3(3):665-73
pubmed: 18337554
Nat Med. 2006 Jul;12(7):829-34
pubmed: 16783372
Mol Psychiatry. 2018 Feb;23(2):344-350
pubmed: 28070126
Cell Biochem Biophys. 2020 Sep;78(3):321-329
pubmed: 32705536
Neuron. 2020 Mar 4;105(5):855-866.e5
pubmed: 31924446
J Neurosci. 2009 Jan 7;29(1):234-49
pubmed: 19129400
Lancet Neurol. 2015 Apr;14(4):388-405
pubmed: 25792098
Nat Rev Neurosci. 2006 Jan;7(1):41-53
pubmed: 16371949
J Biol Chem. 2014 Jun 13;289(24):16773-89
pubmed: 24808182
Blood. 1994 Feb 1;83(3):799-807
pubmed: 8298140
Nature. 2006 Jun 15;441(7095):885-9
pubmed: 16625204
Nat Neurosci. 2016 Aug;19(8):995-8
pubmed: 27294511
Nature. 1986 Feb 6-12;319(6053):499-502
pubmed: 3945333
Biochim Biophys Acta. 2008 Dec;1782(12):691-9
pubmed: 18930136
Prog Neurobiol. 2016 Sep;144:158-72
pubmed: 27498195
Exp Neurol. 2013 Jan;239:133-8
pubmed: 23063604
Cell. 2005 Feb 11;120(3):421-33
pubmed: 15707899
Immunity. 2017 Jun 20;46(6):957-967
pubmed: 28636962
J Am Soc Nephrol. 2003 Oct;14(10):2534-43
pubmed: 14514731
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):2012-2017
pubmed: 28167760
Trends Neurosci. 2009 Dec;32(12):638-47
pubmed: 19782411
Neuron. 2022 Nov 2;110(21):3458-3483
pubmed: 36327895
Neuron. 2020 Nov 25;108(4):608-622
pubmed: 32898475
J Comp Neurol. 2009 Apr 10;513(5):532-41
pubmed: 19226510
Front Aging Neurosci. 2016 Dec 15;8:303
pubmed: 28018215
J Biol Chem. 2012 Jan 2;287(1):159-169
pubmed: 22084236
Cell. 2005 Dec 29;123(7):1293-305
pubmed: 16377569
Arch Gen Psychiatry. 1998 Sep;55(9):809-15
pubmed: 9736007
Aging Dis. 2019 Jun 01;10(3):664-675
pubmed: 31165009
Cell. 2007 Dec 14;131(6):1164-78
pubmed: 18083105
Trends Immunol. 2020 Sep;41(9):758-770
pubmed: 32819810
Front Cell Neurosci. 2013 Apr 17;7:45
pubmed: 23616747
Genomics. 1997 Oct 1;45(1):17-23
pubmed: 9339356
Trends Endocrinol Metab. 2017 May;28(5):388-397
pubmed: 28214071
Nat Rev Immunol. 2018 Apr;18(4):225-242
pubmed: 29151590
Stroke. 2014 Jul;45(7):2085-92
pubmed: 24916903
Annu Rev Immunol. 2017 Apr 26;35:441-468
pubmed: 28226226
Nat Neurosci. 2021 Mar;24(3):312-325
pubmed: 33589835
Sci Rep. 2018 Feb 8;8(1):2629
pubmed: 29422555
Prog Neurobiol. 2018 Mar;162:37-69
pubmed: 29247683
J Neurosci. 2009 Sep 16;29(37):11511-22
pubmed: 19759299
Prog Neurobiol. 2015 Aug;131:120-36
pubmed: 26159707
Annu Rev Nutr. 2017 Aug 21;37:103-130
pubmed: 28628361
Nat Neurosci. 2007 Nov;10(11):1369-76
pubmed: 17965657
Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1834-9
pubmed: 16446425
Mol Metab. 2013 May 09;2(3):161-70
pubmed: 24049731
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):4016-21
pubmed: 18299572
Nat Rev Neurol. 2019 Oct;15(10):565-581
pubmed: 31501588
Autophagy. 2023 Aug;19(8):2296-2317
pubmed: 36781380
Mol Cell. 2002 Nov;10(5):1045-56
pubmed: 12453413
Nature. 2016 Apr 14;532(7598):195-200
pubmed: 27027288
J Neurol Sci. 2011 Jun 15;305(1-2):28-33
pubmed: 21463871
Nat Rev Neurosci. 2013 Feb;14(2):128-42
pubmed: 23329160
Nat Rev Drug Discov. 2022 May;21(5):339-358
pubmed: 35173313
J Cereb Blood Flow Metab. 2014 Aug;34(8):1306-14
pubmed: 24780901
Nature. 2016 Nov 09;539(7628):180-186
pubmed: 27830812
Nature. 2004 Dec 16;432(7019):917-21
pubmed: 15531878
J Neurosci. 2008 Jul 9;28(28):7231-43
pubmed: 18614693
Brain Res. 2013 Apr 10;1505:86-92
pubmed: 23416150
J Biol Chem. 1993 May 15;268(14):10425-32
pubmed: 7683678
Nature. 2012 Mar 28;484(7394):376-80
pubmed: 22456708
Biochemistry. 2000 Feb 29;39(8):1935-41
pubmed: 10684642
Neurochem Res. 2000 Oct;25(9-10):1439-51
pubmed: 11059815
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
Br Med J. 1893 Jul 29;2(1700):227-30
pubmed: 20754383
Science. 2005 May 27;308(5726):1314-8
pubmed: 15831717
Neuroscience. 2004;129(4):877-96
pubmed: 15561405
Nat Neurosci. 2016 Jul 26;19(8):987-91
pubmed: 27459405
Sci Rep. 2020 Aug 7;10(1):13337
pubmed: 32770064
J Pathol. 2004 Nov;204(4):428-37
pubmed: 15495269
Science. 2010 Nov 5;330(6005):774-8
pubmed: 21051628
J Immunol. 2007 Sep 1;179(5):3231-41
pubmed: 17709539
Glia. 2007 Sep;55(12):1214-1221
pubmed: 17659528

Auteurs

Byung-Kwon Jung (BK)

Department of Life Science, University of Seoul, Seoul, 02504, Republic of Korea.

Kwon-Yul Ryu (KY)

Department of Life Science, University of Seoul, Seoul, 02504, Republic of Korea. kyryu@uos.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH